102 results on '"Sowers, James R"'
Search Results
2. Utility of obesity and metabolic dyslipidemia (a non‐insulin based determinate of the metabolic syndrome and insulin resistance) in predicting arterial stiffness
3. Mineralocorticoid antagonists and ENaC inhibitors in hyperaldosteronism
4. Estrogen receptor alpha mediated activation of the endothelial epithelial sodium channel: role in the genesis of arterial stiffness
5. Enhanced epithelial sodium channel signaling in endothelial cells promotes arterial stiffness
6. Reversing glycocalyx degradation; identification of a pharmacological target to improve endothelial function in type II diabetes
7. Endothelial cell‐specific knockout of epithelial sodium channel prevents vascular stiffening in response to a western diet in female mice
8. Absence of Endothelial Estrogen Receptor Alpha Decreases Stiffness and Induces Outward Hypertrophic Remodeling in the Resistance Arteries of Male Mice Fed a Western Diet
9. The dipeptidyl peptidase IV inhibitor saxagliptin prevents angiotensin II‐induced cardiac diastolic dysfunction: potential involvement of cardiac lymphocytes?
10. Amiloride reduces ENaC content and enhances endothelial dependent dilation in mesenteric arteries of female mice fed a Western diet
11. Dipeptidyl Peptidase‐4 (DPP‐4) inhibition with linagliptin reduces the induction of proinflammatory/profibrotic TRAF3IP2 in the hearts of female mice fed a Western Diet
12. Endothelial specific epithelial sodium channel activation prompts vascular stiffness in female mice
13. Xanthine oxidase inhibition attenuates arterial stiffness and prevents macrophage recruitment and M1 polarization in western diet fed male mice
14. Contribution of Maladaptive Adipose Tissue Expansion to Development of Cardiovascular Disease
15. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis
16. Regular exercise reduces endothelial and whole artery stiffness in Western diet‐fed female mice
17. Metabolic Control of Blood Pressure Variability in Humans
18. DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat
19. New insights into insulin action and resistance in the vasculature
20. Characterization of the coronary vascular transcriptome in a rat model of metabolic syndrome
21. Differential Remodeling Characteristics of Femoral and Mesenteric Arteries from Mice with Diet‐Induced Obesity
22. Enhanced coronary vasoconstriction in western diet‐induced obesity is associated with alterations in NHE1, SERCA2a and 3
23. Impaired Ca 2+ signaling following acutely elevated glucose in mouse endothelial cell tubes
24. Randomized Study of Antihypertensive Efficacy and Safety of Combination Aliskiren/Valsartan vs Valsartan Monotherapy in Hypertensive Participants With Type 2 Diabetes Mellitus
25. Does Response of RAS Blockade on Serum K+ Levels Influence Its Glycemic-Mitigating Response When Combined With Hydrochlorothiazide?
26. Modulation of microRNA miR‐29c in a novel cross‐talk between mTOR complex 1 and Angiotensin II type 2 receptor AT2R: an adaptive mechanism in over‐nutrition
27. Evidence‐Based Hypertension Treatment in Patients With Diabetes
28. Office and Ambulatory Blood Pressure-Lowering Effects of Combination Valsartan/Hydrochlorothiazide vs Hydrochlorothiazide-Based Therapy in Obese, Hypertensive Patients
29. Effect of Age in RAS Activation and Insulin Signaling in the Pancreatic Tissue of db/db Mice
30. Nebivolol‐mediated Inhibition of Nutrient Sensor mTOR‐ and Inflammatory Marker JAK2‐mediated Signaling in Myocardium: Involvement of Angiotensin II Receptors
31. Is it Time to Target Prehypertension
32. Surgical Cure of Hypertension in a Patient With MEN 2A Syndrome and Mixed Dopamine, Metanephrine Pheochromocytoma
33. Malignant Pheochromocytoma Presenting With Uncontrolled Hypertension After Kidney Transplant
34. Renin-Angiotensin-Aldosterone System Inhibition and Improvement in Glucose Tolerance
35. Joint Publication of Journal of the CardioMetabolic Syndrome and The Journal of Clinical Hypertension
36. Role of aldosterone and angiotensin II in insulin resistance: an update
37. Realities of Newer β‐Blockers for the Management of Hypertension
38. Nebivolol in Obese and Non‐Obese Hypertensive Patients
39. Mineralocorticoid Receptor (MR) Inhibition Attenuates High Salt‐Aldosterone Induced Increases in Vascular Renin‐Angiotensin‐Aldoesterone System (RAAS) and Oxidative Stress
40. Direct renin inhibition with Aliskiren lowers blood pressure and improves renal dysfunction in Ren2 rats
41. Rosuvastatin Attenuates Pulmonary Arterial Hypertension in the Transgenic (mREN2)27 (Ren2) Rat
42. Mineralcorticoid Receptor (MR) Antagonism Attenuates Glomerular Filtration Barrier Remodeling in the Transgenic Ren2 Rat
43. Utility of Aspirin Therapy in Patients With the Cardiometabolic Syndrome and Diabetes
44. ADVANCE: Blood Pressure Lowering in Diabetes
45. Progress and Controversies: Treating Obesity and Insulin Resistance in the Context of Hypertension
46. Blood Pressure Control in the Patient With Difficult-to-Control Hypertension: Which Agent for Which Patient?
47. Metabolic and Antihypertensive Effects of Combined Angiotensin Receptor Blocker and Diuretic Therapy in Prediabetic Hypertensive Patients With the Cardiometabolic Syndrome
48. The Cardiometabolic Syndrome and Liver Disease
49. Reversal of Diuretic-Associated Impaired Glucose Tolerance and New-Onset Diabetes: Results of the STAR-LET Study
50. Attenuation of Endocrine-Exocrine Pancreatic Communication in Type 2 Diabetes: Pancreatic Extracellular Matrix Ultrastructural Abnormalities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.